PS Ratio: 21.01

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 21.01 is 90% below its estimated 1-year average of 216.49, near the low end of its estimated 1-year range (20.86–735.20).

As of 2026-10-06T19:57:25.457Z.

JUNS PS Ratio Metrics

P/S vs. estimated history

At 21.01, P/S is at an extreme level, where the multiple carries little signal — higher than 1% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Jupiter Neurosciences, Inc. (JUNS)?

The P/S ratio for JUNS stock is 21.01.

Is Jupiter Neurosciences, Inc.'s P/S ratio high or low?

The P/S ratio of 21.01 is 90% below its estimated 1-year average of 216.49, near the low end of its estimated 1-year range (20.86–735.20).

Related Metrics